{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "N-Acétyl-S-nitroso-pénicillamine : Questions médicales les plus fréquentes",
"headline": "N-Acétyl-S-nitroso-pénicillamine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les N-Acétyl-S-nitroso-pénicillamine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-16",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "N-Acétyl-S-nitroso-pénicillamine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pénicillamine",
"url": "https://questionsmedicales.fr/mesh/D010396",
"about": {
"@type": "MedicalCondition",
"name": "Pénicillamine",
"code": {
"@type": "MedicalCode",
"code": "D010396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.125.166.786"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "N-Acétyl-S-nitroso-pénicillamine",
"alternateName": "S-Nitroso-N-Acetylpenicillamine",
"code": {
"@type": "MedicalCode",
"code": "D026423",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Benjamin Gaston",
"url": "https://questionsmedicales.fr/author/Benjamin%20Gaston",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Pulmonology, Indiana University School of Medicine, Indianapolis, Indiana, USA."
}
},
{
"@type": "Person",
"name": "Hitesh Handa",
"url": "https://questionsmedicales.fr/author/Hitesh%20Handa",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical, Materials, and Biomedical Engineering, University of Georgia, Athens, Georgia."
}
},
{
"@type": "Person",
"name": "Alfred Hausladen",
"url": "https://questionsmedicales.fr/author/Alfred%20Hausladen",
"affiliation": {
"@type": "Organization",
"name": "Institute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH, USA."
}
},
{
"@type": "Person",
"name": "Jonathan S Stamler",
"url": "https://questionsmedicales.fr/author/Jonathan%20S%20Stamler",
"affiliation": {
"@type": "Organization",
"name": "Institute for Transformative Molecular Medicine, Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH, USA. jonathan.stamler@case.edu."
}
},
{
"@type": "Person",
"name": "James N Bates",
"url": "https://questionsmedicales.fr/author/James%20N%20Bates",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesia, University of Iowa, Iowa City, Iowa, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Chemical reversion of age-related oocyte dysfunction fails to enhance embryo development in a bovine model of postovulatory aging.",
"datePublished": "2024-06-01",
"url": "https://questionsmedicales.fr/article/38822989",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10815-024-03151-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changes in Symptoms and General Well-being After Reversal of Roux-en-Y Gastric Bypass: A Questionnaire Survey.",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38811426",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11695-024-07321-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Triply Interlocked [2]catenanes: Rational Synthesis, Reversible Conversion Studies and Unprecedented Application in Photothermal Responsive Elastomer.",
"datePublished": "2024-05-20",
"url": "https://questionsmedicales.fr/article/38766881",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/anie.202406552"
}
},
{
"@type": "ScholarlyArticle",
"name": "Electromyographic analysis of selected shoulder muscles during shoulder rehabilitation exercises in patients after reversed shoulder arthroplasty.",
"datePublished": "2024-05-14",
"url": "https://questionsmedicales.fr/article/38754545",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jse.2024.03.050"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of novel N-aryl-2,4-bithiazole-2-amine-based CYP1B1 degraders for reversing drug resistance.",
"datePublished": "2024-05-08",
"url": "https://questionsmedicales.fr/article/38733885",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejmech.2024.116488"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides aminés",
"item": "https://questionsmedicales.fr/mesh/D000596"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides aminés soufrés",
"item": "https://questionsmedicales.fr/mesh/D000603"
},
{
"@type": "ListItem",
"position": 5,
"name": "Pénicillamine",
"item": "https://questionsmedicales.fr/mesh/D010396"
},
{
"@type": "ListItem",
"position": 6,
"name": "N-Acétyl-S-nitroso-pénicillamine",
"item": "https://questionsmedicales.fr/mesh/D026423"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : N-Acétyl-S-nitroso-pénicillamine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur N-Acétyl-S-nitroso-pénicillamine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur N-Acétyl-S-nitroso-pénicillamine",
"description": "Comment diagnostiquer une carence en N-Acétyl-S-nitroso-pénicillamine ?\nQuels examens sont nécessaires pour évaluer son efficacité ?\nQuels symptômes indiquent un besoin de traitement ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?\nComment évaluer les effets secondaires du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D026423?mesh_terms=HIV+Reverse+Transcriptase&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur N-Acétyl-S-nitroso-pénicillamine",
"description": "Quels sont les symptômes d'une surdose ?\nComment se manifestent les effets vasodilatateurs ?\nQuels signes indiquent une réaction allergique ?\nQuels symptômes sont liés à une carence ?\nComment reconnaître une intolérance au médicament ?",
"url": "https://questionsmedicales.fr/mesh/D026423?mesh_terms=HIV+Reverse+Transcriptase&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur N-Acétyl-S-nitroso-pénicillamine",
"description": "Comment prévenir les complications liées au traitement ?\nQuelles habitudes de vie peuvent aider ?\nEst-il nécessaire de surveiller la pression artérielle ?\nQuels examens préventifs sont recommandés ?\nComment éviter les interactions médicamenteuses ?",
"url": "https://questionsmedicales.fr/mesh/D026423?mesh_terms=HIV+Reverse+Transcriptase&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur N-Acétyl-S-nitroso-pénicillamine",
"description": "Comment administrer le N-Acétyl-S-nitroso-pénicillamine ?\nQuels sont les traitements associés ?\nQuelle est la durée du traitement ?\nY a-t-il des alternatives au traitement ?\nComment gérer les effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D026423?mesh_terms=HIV+Reverse+Transcriptase&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur N-Acétyl-S-nitroso-pénicillamine",
"description": "Quelles sont les complications possibles du traitement ?\nComment reconnaître une complication grave ?\nQuels facteurs augmentent le risque de complications ?\nComment gérer les complications si elles surviennent ?\nY a-t-il des complications à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D026423?mesh_terms=HIV+Reverse+Transcriptase&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur N-Acétyl-S-nitroso-pénicillamine",
"description": "Quels sont les principaux facteurs de risque ?\nComment l'alimentation influence-t-elle le risque ?\nLe tabagisme est-il un facteur de risque ?\nL'âge joue-t-il un rôle dans le risque ?\nComment le stress affecte-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D026423?mesh_terms=HIV+Reverse+Transcriptase&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en N-Acétyl-S-nitroso-pénicillamine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour évaluer son efficacité ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction vasculaire et des mesures de pression artérielle sont recommandés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de traitement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des palpitations ou une hypertension peuvent signaler un besoin."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biomarqueurs spécifiques peuvent aider à évaluer l'état oxydatif et vasculaire."
}
},
{
"@type": "Question",
"name": "Comment évaluer les effets secondaires du traitement ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec des tests cliniques et des questionnaires sur les symptômes est essentiel."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surdose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des vertiges et des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les effets vasodilatateurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se manifestent par des rougeurs, une baisse de la pression artérielle et des palpitations."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une réaction allergique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, des démangeaisons ou un gonflement peuvent signaler une allergie."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une carence ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une fatigue excessive, des douleurs musculaires et des troubles de la concentration peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une intolérance au médicament ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, des vomissements ou des douleurs abdominales peuvent indiquer une intolérance."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées au traitement ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et une évaluation des facteurs de risque sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie peuvent aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et l'arrêt du tabac sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Est-il nécessaire de surveiller la pression artérielle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière de la pression artérielle est cruciale pour éviter des complications."
}
},
{
"@type": "Question",
"name": "Quels examens préventifs sont recommandés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cardiovasculaires réguliers et des bilans sanguins sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment éviter les interactions médicamenteuses ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important de discuter de tous les médicaments avec le médecin pour éviter les interactions."
}
},
{
"@type": "Question",
"name": "Comment administrer le N-Acétyl-S-nitroso-pénicillamine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est généralement administré par voie orale ou intraveineuse selon la condition traitée."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements associés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut être associé à des antihypertenseurs ou des anticoagulants pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Quelle est la durée du traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée dépend de la condition traitée, mais un suivi régulier est nécessaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des alternatives au traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des alternatives incluent d'autres vasodilatateurs ou des modifications du mode de vie."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est important de signaler tout effet secondaire au médecin pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du traitement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des hypotensions, des réactions allergiques ou des troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une complication grave ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des douleurs thoraciques sévères ou des difficultés respiratoires nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux, l'âge avancé et la prise de plusieurs médicaments augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications si elles surviennent ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de consulter un médecin immédiatement pour évaluer et traiter les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des problèmes cardiovasculaires ou rénaux."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète et un mode de vie sédentaire."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en graisses saturées et en sel augmente le risque de complications."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque majeur pour les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 50 ans."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à l'hypertension et à d'autres problèmes de santé."
}
}
]
}
]
}
There are no clinical treatments to prevent/revert age-related alterations associated with oocyte competence decline in the context of advanced maternal age. Those alterations have been attributed to ...
Bovine immature oocytes were matured in vitro for 23 h (young) and 30 h (aged). Postovulatory aged oocytes (control group) and embryos obtained after fertilization were examined and compared with oocy...
Aged oocytes had a significantly lower mitochondrial mass and proportion of mitochondrial clustered pattern, lower ooplasmic volume, higher ROS, lower sirtuin-1 protein level, and a lower blastocyst r...
Resveratrol and phloretin can both revert the age-related oxidative stress and mitochondrial dysfunction during postovulatory aging but were insufficient to enhance embryo developmental rates under ou...
After Roux-en-Y gastric bypass (RYGB), few patients develop severe complications, which ultimately may require reversal of RYGB. We aimed to examine the effect of reversal of RYGB on symptoms and well...
Via contact to medical and surgical departments treating patients with RYGB, we identified 18 patients, who had undergone reversal, 2009-2019. We conducted a Danish, nationwide questionnaire survey co...
Fourteen patients responded to the questionnaire (86% female; median age at RYGB, 36.2 years [IQR, 30.9-38.6 years]). The median time from RYGB to reversal was 5.8 years (IQR, 5.1-7.5 years). After RY...
In total, 72% of the patients felt better or much better after reversal of RYGB, though some still had RYGB-related symptoms. The reversal relieved dumping/PBH and malabsorption, but not abdominal pai...
Triply interlocked [2]catenane complexes featuring two identical, mechanically interlocked units are extraordinarily rare chemical compounds, whose properties and applications remain open to detailed ...
Reversed shoulder arthroplasty (RSA) aims to restore function in patients with rotator cuff failure and joint arthropathy. After surgery, patients are routinely referred to a rehabilitation specialist...
Forty-four patients (50 shoulders) participated in this cross-sectional study, 12 weeks postoperatively (mean 99.18±12.8 days), aged 68.9±7.75 years. Surface EMG activity was measured in 10 shoulder g...
Gravity- minimized exercises (horizontal plane) show low activity for almost all muscles. Vertical closed kinetic chain exercises show an increased activity compared to horizontal plane exercises. Ope...
This study offers a progression of exercises for patients after reversed shoulder arthroplasty based on increased muscle activity....
Extrahepatic cytochrome P450 1B1 (CYP1B1), which is highly expressed in non-small cell lung cancer, is an attractive target for cancer prevention, therapy, and overcoming drug resistance. Historically...
A 73-year-old man with chronic obstructive pulmonary disease received the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine. The following day, the patient developed a headache...
This study examined the effects of nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) on folliculogenesis and mitochondrial dynamics (fission and fusion mechanisms) in ovaries of middle-...
Experimental groups were young, middle-aged (control), middle-aged + NMN and middle-aged + NR. NMN was administered at a concentration of 500 mg/kg intraperitoneally but NR at a concentration of 200 m...
Higher ovarian index, more corpus luteum and antral follicles were detected in NMN and NR groups compared to the control. NMN or NR could rebalance LH/FSH ratio. The control group was determined to po...
This study reveals that NMN alone or NR alone can rebalance mitochondrial dynamics by decreasing excessive fission in middle-aged rat ovaries, thus alleviating mitochondrial stress and correcting agin...
Stoma site incisional hernias (SSIHs) are associated with substantial long-term morbidity, and the rate can be as high as 30% to 40%. Recent efforts using prophylactic mesh reinforcement (PMR) to redu...
This is an observational retrospective cohort study. A review of 101 consecutive patients who underwent PMR in the retrorectus plane from 2015 to 2020 was compared to 73 consecutive patients who under...
In total, 174 cases were analyzed with 101 patients in the treatment group (median follow-up 45.2 months) and 73 patients in the control group (median follow-up 43.2 months). There were no major diffe...
PMR with biosynthetic mesh at the time of stoma reversal and closure is an effective procedure to reduce the incidence of SSIHs and does not seem to be associated with an increased risk of complicatio...
Methamphetamine is an illegal drug that poses serious public health concerns worldwide. Previous studies have demonstrated a strong association between methamphetamine abuse and non-lethal haemorrhagi...
A retrospective data analysis was performed for the young methylamphetamine addict admitted to a hospital for acute ischaemic stroke followed by a literature review to explore the possible pathogenesi...
The patient had been receiving methamphetamine for past 2 years. His recurrent headache occurred half an hour after each consumption and was relieved within a few hours. The patient was admitted for a...
For young patients with a stroke, a thorough investigation of the history of illicit drug use and toxicological screening of urine and serum samples should be performed. Young methamphetamine users ne...
The utility of 4-factor prothrombin complex concentrate (4F-PCC) for reversal in patients on factor Xa inhibitors (XaI) is unclear, specifically in mild traumatic brain injury (mTBI). This is a retros...